On the recordDecember 7, 2021
Eliminating just one new drug is one drug too many. What if one of those new drugs is a cure for Alzheimer's, cancer, or ALS?
Source
congress.govLarry Bucshon: “Eliminating just one new drug is one drug too many. What if one of those new drugs is a cure for Alzheimer's, cancer, or…”
Editor's note · Context
Bucshon emphasizes the critical need for new drugs and the potential consequences of their absence.
Share
More from Larry Bucshon
May 14, 2024
I have one additional speaker. Mr. Speaker, I yield 1 minute to the gentleman from Georgia (Mr. Carter).
Jul 25, 2023
I also urge support for H.R. 752, the Securing Semiconductor Supply Chains Act of 2023, as amended, and I yield back the balance of my time. The SPEAKER pro tempore (Mrs. Miller-Meeks). The question is on the motion offered by the…
Apr 18, 2023
I strongly support the 340B program, but we certainly need more transparency.
Jan 10, 2024
I thank the gentleman for yielding. I am rising today to advocate for America's patients and their physicians. Over the past 3 years, doctors across the Nation have more than stepped up to the challenges that they have encountered, COVID…
Other voices in this conversation
